Margin Call
Sector · Margin Call

Biotech & Gene Therapy

Biotech companies developing gene editing (CRISPR), mRNA, cell therapy, and gene therapies. A high-volatility sector where stock prices react sharply to clinical trial events.

Representative stocks (8)

Related learning

This sector analysis is general reference information and does not recommend buying or selling any specific stock.

Your watchlist as a home screen widget